Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial

Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials

(2015) Sakima A. Smith et al.   AMERICAN JOURNAL OF CARDIOLOGY

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease

(2015) Bertram Pitt et al.   EUROPEAN JOURNAL OF HEART FAILURE

Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation

(2015) Gregory Y.H. Lip et al.   EUROPEAN JOURNAL OF HEART FAILURE

Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response

(2015) David P. Kao et al.   EUROPEAN JOURNAL OF HEART FAILURE

Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial

(2015) Stephen J. Greene et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction

(2015) Mihai Gheorghiade et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Potential Role of Natriuretic Peptide–Guided Management for Patients Hospitalized for Heart Failure

(2015) Alan Maisel et al.   JOURNAL OF CARDIAC FAILURE

Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor

(2015) G. Michael Felker et al.   JACC-Heart Failure

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

(2014) B. A. Steinberg et al.   EUROPEAN HEART JOURNAL

Matching Mechanism of Death With Mechanism of Action

(2014) Stephen J. Greene et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis

(2014) Dipak Kotecha et al.   LANCET

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rationale and Design of the GUIDE-IT Study

(2014) G. Michael Felker et al.   JACC-Heart Failure

Is Heart Rate Important for Patients With Heart Failure in Atrial Fibrillation?

(2014) Damien Cullington et al.   JACC-Heart Failure

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

(2013) Faiez Zannad et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure

(2013) Mihai Gheorghiade et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The disconnect between phase II and phase III trials of drugs for heart failure

(2013) Muthiah Vaduganathan et al.   Nature Reviews Cardiology

Atrial Fibrillation Impairs the Diagnostic Performance of Cardiac Natriuretic Peptides in Dyspneic Patients

(2013) Mark Richards et al.   JACC-Heart Failure

Beta-Blockers and Outcome in Heart Failure and Atrial Fibrillation

(2013) Michiel Rienstra et al.   JACC-Heart Failure

Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial

(2012) Robert J. Mentz et al.   AMERICAN HEART JOURNAL

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

(2012) Scott D Solomon et al.   LANCET

Atrial Fibrillation and Mortality in Heart Failure

(2011) Alanna M. Chamberlain et al.   Circulation-Heart Failure

Clinical development of pharmacologic agents for acute heart failure syndromes: A proposal for a mechanistic translational phase

(2010) Mihai Gheorghiade et al.   AMERICAN HEART JOURNAL

Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)

(2010) Mihai Gheorghiade et al.   EUROPEAN JOURNAL OF HEART FAILURE

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Are BNP Changes During Hospitalization for Heart Failure a Reliable Surrogate for Predicting the Effects of Therapies on Post-Discharge Mortality?⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.

(2009) Mihai Gheorghiade et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin

(2009) John G.F. Cleland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY